Related Experiment Video
Updated: Mar 25, 2026

10:43
Analysis of Microglia and Monocyte-derived Macrophages from the Central Nervous System by Flow Cytometry
Published on: June 22, 2017
25.3K
Peripheral monocytes are functionally altered and invade the CNS in ALS patients
Lisa Zondler1, Kathrin Müller1, Samira Khalaji2
1Department of Neurology, Ulm University, Albert-Einstein Allee 11, O25, Niveau 5, 89081, Ulm, Germany.
Acta Neuropathologica
|February 25, 2016
Summary
Peripheral monocytes are deregulated in amyotrophic lateral sclerosis (ALS). Increasing their central nervous system (CNS) infiltration may protect motor neurons and delay disease progression in ALS patients.
Area of Science:
- Neuroimmunology
- Neurodegenerative Diseases
Background:
- Amyotrophic lateral sclerosis (ALS) involves neuroinflammation in the central nervous system (CNS).
- The role of the peripheral immune system in ALS pathogenesis is not well understood.
- Peripheral monocytes' interaction with CNS immune cells in motor neuron degeneration requires further investigation.
Purpose of the Study:
- To characterize peripheral monocytes in amyotrophic lateral sclerosis (ALS) pathogenesis.
- To investigate the role of peripheral monocytes in motor neuron survival.
- To explore therapeutic strategies targeting peripheral monocytes in ALS.
Main Methods:
- Characterization of circulating monocyte subtypes, function, and gene expression in ALS.
- Assessment of CNS infiltration of peripheral monocytes in a genetic ALS mouse model.
- Evaluation of human immunoglobulins and Fc-containing fusion proteins for their effect on monocyte infiltration and disease onset.
Main Results:
- Circulating monocytes exhibit deregulation in ALS concerning subtype, function, and gene expression.
- Increased CNS infiltration of peripheral monocytes correlates with enhanced motor neuron survival in an ALS mouse model.
- Human immunoglobulins and Fc fragments promote monocyte CNS invasion and delay disease onset.
Conclusions:
- Peripheral monocytes play a significant role in ALS pathogenesis.
- Monocytes may exert a protective effect in the early stages of ALS.
- Targeting peripheral monocyte function, potentially with human immunoglobulins, warrants clinical evaluation for ALS treatment.

